Management of atrial fibrillation

Current Problems in Cardiology

Volumn 30, Issue 4, 2005, Pages 175-233

  Hersi, A ^e   Wyse, D G ^{a,b,c,d,e,f,g,h}  

^a ASTRAZENECA   (United Kingdom)

^b Cardiome Pharma Fujisawa   (Japan)

^c PROCTER AND GAMBLE COMPANY   (United States)

^d Orion Pharma Abbott   (United States)

^e Medtronic ^*

^f BRISTOL MYERS SQUIBB   (United States)

^g Pfizer

^h Chugai Pharma   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DOFETILIDE; ESMOLOL; FLECAINIDE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUTILIDE; MAGNESIUM SULFATE; METOPROLOL; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN; XIMELAGATRAN;

ALGORITHM; ASTHMA; BLEEDING; BLINDNESS; BRADYCARDIA; BRAIN HEMORRHAGE; CARDIOVERSION; CATHETER ABLATION; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONSTIPATION; DIGITALIS INTOXICATION; DRUG CLEARANCE; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; EDEMA; EMBOLISM; EYE TOXICITY; FLUSHING; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM THROMBOSIS; HEART BLOCK; HEART DISEASE; HEART FAILURE; HEART PACING; HEART PROARRHYTHMIA; HEART RATE; HEART RHYTHM; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; LIVER TOXICITY; LOW DRUG DOSE; MEDICAL DECISION MAKING; NEUROPATHY; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY ABLATION; RETINA DISEASE; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; SIDE EFFECT; SINUS RHYTHM; STROKE; SUSTAINED DRUG RELEASE; THROMBOEMBOLISM; THYROID DISEASE; TORSADE DES POINTES; URINE RETENTION; VISUAL IMPAIRMENT; WOLFF PARKINSON WHITE SYNDROME; XEROSTOMIA;

EID: 15244360556     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2004.09.002     Document Type: Article

References (201)

1. S. Bellet Clinical Disorders of the Heart Beat 3rd ed. 1971 Lea & Febiger Philadelphia, PA
2. S. Levy Epidemiology and classification of atrial fibrillation J Cardiovasc Electrophysiol 9 1998 S78 S82
3. S.M. Sopher, A.J. Camm Therapy for atrial fibrillation control of the ventricular response and prevention of recurrence Coron Artery Dis 6 1995 106 114
4. V. Fuster, L.E. Ryden, R.W. Asinger ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with North American Society of Pacing and Electrophysiology Eur Heart J 22 2001 1852 1923
5. S. Nattel, D. Li, L. Yue Basic mechanisms of atrial fibrillation--very new insights into very old ideas Annu Rev Physiol 62 2000 51 77
6. M. Haissaguerre, P. Jais, D.C. Shah Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
7. M.C. Wijffels, C.J. Kirchhof, R. Dorland, M.A. Allessie Atrial fibrillation begets atrial fibrillation a study in awake chronically instrumented goats Circulation 92 1995 1954 1968
8. D.G. Wyse, B.J. Gersh Atrial fibrillation: a perspective: thinking inside and outside the box Circulation 109 2004 3089 3095
9. A.L. Waldo Mechanisms of atrial flutter and atrial fibrillation distinct entities or two sides of a coin? Cardiovasc Res 54 2002 217 229
10. D. Li, A. Benardeau, S. Nattel Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation Circulation 102 2000 104 112
11. A. Go, E.M. Hylek, K.A. Philips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial fibrillation study (ATRIA) JAMA 285 2001 2370 2375
12. W.B. Kannel, R.D. Abbott, D.D. Savage, P.M. McNamara Epidemiologic features of chronic atrial fibrillation the Framingham study N Engl J Med 306 1982 1018 1022
13. S.S. Chugh, J.L. Blackshear, W.K. Shen, S.C. Hammill, B.J. Gersh Epidemiology and natural history of atrial fibrillation clinical implications J Am Coll Cardiol 2001 371 378
14. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implication Arch Intern Med 155 1995 469 473
15. B.M. Psaty, T.A. Manolio, L.H. Kuller Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461
16. A. Majeed, K. Moser, K. Carroll Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales 1994-1998 analysis of data from the general practice research database Heart 86 2001 284 288
17. A.D. Krahn, J. Manfreda, R.B. Tate, F.A. Mathewson, T.E. Cuddy The natural history of atrial fibrillation incidence, risk factors, and prognosis in the Manitoba Follow-up Study Am J Med 98 1995 476 484
18. C.D. Furberg, T.A. Manolio, B.M. Psaty Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study) Am J Cardiol 69 1992 1329 1335
19. W.B. Kannel, P.A. Wolf, E.J. Benjamin, D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation a population-based estimate Am J Cardiol 82 1998 2N 9N
20. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
21. L. Frost, S.P. Johnsen, L. Pedersen Seasonal variation in hospital discharge diagnosis of atrial fibrillation a population-based study Epidemiology 13 2002 211 215
22. C.D. Furberg, B.M. Psaty, T.A. Manolio, J.M. Gardin, V.E. Smith, P.M. Rautaharju Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241
23. P.A. Wolf, R.D. Abbott, W.B. Kannel Atrial fibrillation as an independent risk factor for stroke the Framingham Study Stroke 22 1991 983 988
24. W.H. Maisel, L.W. Stevenson Atrial fibrillation in heart failure epidemiology, pathophysiology, and rational for therapy Am J Cardiol 91 2003 2D 8D
25. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, D. Levy Impact of atrial fibrillation on the risk of death the Framingham Heart study Circulation 98 1998 946 952
26. M.M. Redfield, G.N. Kay, L.S. Jenkins, M. Mianulli, D.N. Jensen, K.A. Ellenbogen Tachycardia-related cardiomyopathy a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation Mayo Clin Proc 75 2000 790 795
27. R.J. Aviles, D.O. Martin, C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
28. E.D. Eaker, L.M. Sullivan, M. Kelly-Hayes, R.B. D'Agostino Sr, E.J. Benjamin Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study Circulation 109 2004 1267 1271
29. L. Djousse, D. Levy, E.J. Benjamin Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study Am J Cardiol 93 2004 710 713
30. G.D. Friedman, D.B. Loveland, S.P. Ehrlich Jr Relationship of stroke to other cardiovascular disease Circulation 38 1968 533 541
31. P.A. Wolf, R.D. Abbott, W.B. Kannel Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study Arch Intern Med 147 1987 1561 1564
32. Atrial Fibrillation Investigators Risk factor for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
33. P.A. Kempster, R.P. Gerraty, P.C. Gate Asymptomatic cerebral infarction in patients with chronic atrial fibrillation Stroke 19 1988 955 957
34. M. Cullinane, R. Waingright, A. Brown, M. Monaghan, H.S. Markus Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants a prospective study Stroke 29 1998 1810 1815
35. M.D. Ezekowitz, K.E. James, S.M. Nazarian Silent cerebral infarction in patients with non-rheumatic atrial fibrillation Circulation 92 1995 2178 2182
36. S.L. Kopecky, B.J. Gersh, M.D. McGoon The natural history of lone atrial fibrillation. A population based study over three decades N Engl J Med 317 1987 669 674
37. The Atrial Fibrillation Investigators Risk factor for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
38. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Lancet 342 1993 1255 1262
39. The SPAF III Investigators Adjusted-dose warfarin versus low intensity fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation. Stroke Prevention Trial in Atrial Fibrillation III randomized clinical trial Lancet 348 1996 633 638
40. R.G. Hart, L.A. Pearce, R. McBride, R.M. Rothbart, R.W. Asinger The stroke prevention in atrial fibrillation (SPAF) investigators Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation analysis of 2012 participant in the SPA I-III clinical trials Stroke 30 1999 1223 1229
41. G.W. Albers, J.E. Dalen, A. Laupacis, W.J. Manning, P. Petersen, D.E. Singer Antithrombotic therapy in atrial fibrillation Chest 119 2001 194S 206S
42. M.D. Ezekowitz, S.L. Bridgers, K.E. James Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
43. The Boston Area Anticoagulation Trial of Atrial Fibrillation Investigator The effect of low dose Warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 323 1990 1505 1511
44. The SPF Investigators Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk the Stroke Prevention in Atrial Fibrillation Investigators Arch Intern Med 116 1992 1 5
45. The SPAF Investigators Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators Arch Intern Med 116 1992 6 12
46. A.W. Moulton, D.E. Singer, J.S. Haas Risk factors for stroke in patients with nonrheumatic atrial fibrillation a case-control study Am J Med 91 1991 156 161
47. K.M. Flegel, J. Hanley Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation Stroke 20 1989 1000 1004
48. Stroke Prevention in Atrial Fibrillation Investigator Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation the Stroke Prevention Atrial Fibrillation Study J Stroke Cerebrovasc Dis 5 1995 147 157
49. W.S. Aronow, C. Ahn, I. Kronzon, H. Gutstein Risk factors for new thromboembolic stroke in patients < or =62 years with chronic atrial fibrillation Am J Cardiol 82 1998 119 121
50. C. Stollberger, P. Chnupa, G. Kronik Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation ELAT Group. Embolic in Left Atrial Thrombi Ann Intern Med 128 1998 630 638
51. P. Peterson, J. Kastrup, S. Helweg-Larsen, G. Boysen, J. Godtfredsen Risk factors for thromboembolic complication in chronic atrial fibrillation. The Copenhagen AFASAK Study Arch Intern Med 150 1990 819 821
52. J.C. Van Latum, P.J. Koudstaal, G.S. Venables, J. van Gijin, L.J. Kappelle, A. Algra European Atrial Fibrillation Trail (EAFT) Study Group Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and nonrheumatic atrial fibrillation Stroke 16 1995 806-6
53. The Atrial Fibrillation Investigators Echocardiographic predictors of stroke in patients with atrial fibrillation a prospective study of 1066 patients from 3 clinical trials Arch Intern Med 158 1998 1316 1320
54. M. Yoshida, Y. Nakamura, M. Higashikawa, M. Kinoshita Predictors of ischemic stroke in non-rheumatic atrial fibrillation Int J Cardiol 56 1996 61 70
55. H. Nakagami, K. Yamamoto, U. Ikeda, T. Mitsuhashi, T. Goto, K. Shimada Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation Am Heart J 136 1998 528 532
56. W.S. Aronow, H. Gutstein, F.Y. Hsieh Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation Am J Cardiol 63 1989 366 367
57. S.J. Connolly, A. Laupacis, M. Gent, R.S. Roberts, J.A. Caims, C. Joyner Canadian Atrial Fibrillation Anticoagulation (CAFA) study J Am Coll Cardiol 18 1991 349 355
58. P. Peterson, G. Boysen, J. Godtfredsen, E.D. Andersen, B. Andersen Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complication in chronic atrial fibrillation the Copenhagen AFASAK study Lancet 1 1989 175 179
59. Stoke Prevention in Atrial Fibrillation Investigator Stroke prevention in atrial fibrillation study final result Circulation 84 1991 527 539
60. Atrial Fibrillation Investigators Risk factor for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
61. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, M.J. Radford Validation of clinical schemes for predicting stroke results from the National Registry of atrial Fibrillation JAMA 285 2001 2864 2870
62. The Atrial Fibrillation Investigators The efficacy of aspirin in patients with atrial fibrillation analysis of pooled data from 3 randomized trials Arch Intern Med 157 1997 1237 1240
63. A.L. Gullov, B.G. Koefoed, P. Petersen Fixed minidose warfarin and aspirin alone in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation. Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Arch Intern Med 158 1998 1513 1521
64. Stroke Prevention in Atrial Fibrillation. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II study Lancet 343 1994 687 691
65. B.S. Hellemons, M. Landenberg, J. Lodder LMLJ. Primary prevention of arterial thromboembolism in nonrheumatic atrial fibrillation in general practice (the PATAF Study) Control Clin Trial 20 1999 386 393
66. R.G. Hart, O. Benavente, R. McBride, L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation a meta-analysis Ann Intern Med 131 1999 492 501
67. C. Wehinger, C. Stollberger, T. Langer, B. Schneider, J. Finsterer Evaluation of risk factors for stroke/embolism and of complication due to anticoagulation therapy in atrial fibrillation Stroke 32 2001 2246 2252
68. E.M. Hylek, D.E. Singer Risk factors of intracranial hemorrhage in outpatients taking warfarin Ann Intern Med 120 1994 897 902
69. S.D. Fihn, C.M. Callahan, D.C. Martin, M.B. McDonell, J.G. Henikoff, R.H. White The risk for and severity of bleeding complication in elderly patients treated with warfarin Ann Intern Med 124 1996 970 979
70. The European Atrial Fibrillation Trial. Optimal oral anticoagulation therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia N Engl J Med 333 1995 5 10
71. P. Petersen, M. Grind, J. Adler Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study J Am Coll Cardiol 41 2003 1445 1451
72. S.B. Olsson Executive Steering Committee on behalf of the SPORTIF III Investigators Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III) randomized controlled trial Lancet 362 2003 1691 1698
73. L.K. Gottlieb, S. Salem-Schatz Anticoagulation in Atrial Fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154 1994 1945 1953
74. D.G. Wyse, A.L. Waldo, J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
75. I.C. Van Gelder, V.E. Hagnes, H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
76. S. Yusuf, F. Zhao, S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
77. J.L. Blackshear, J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759
78. Task Force on Practice Guidelines ACC/AHA guidelines for the management of valvular heart disease. A report of the American College of Cardiology/American Heart Association J Am Coll Cardiol 32 1998 1486 1588
79. H. Sievert, M.D. Lesh, T. Trepels Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation early clinical experience Circulation 105 2002 1887 1889
80. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, H. Amesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
81. S.H. Hohnloser, K.H. Kuck, J. Lilienthal Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF) a randomized trial Lancet 356 2000 1789 1794
82. M. Brignole, C. Menozzi, M. Gasparini An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing in patients with paroxysmal atrial fibrillation Eur Heart J 23 2002 892 900
83. J. Carlsson, S. Miketic, J. Windeler Randomized trial of rate control and rhythm control in patients with persistent atrial fibrillation the Strategies of Treatment of Atrial Fibrillation study (STAF) J Am Coll Cardiol 41 2003 1690 1696
84. D.G. Wyse Rhythm versus rate control trials in atrial fibrillation J Cardiovasc Electrophysiol 14 2003 S35 S39
85. S.E. Coplen, E.M. Antman, J.A. Berlin, P. Hewitt, T.C. Chalmers Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized controlled trials Circulation 82 1990 1106 1116
86. M.R. Miller, R.L. McNamara, J.B. Segal Efficacy of agents for pharmacological conversion of atrial fibrillation and subsequent maintenance of sinus rhythm a meta-analysis of clinical trials J Fam Pract 49 2000 1033 1046
87. G.C. Flaker, J.L. Blackshear, R. McBride, R.A. Kronmal, J.L. Halperin, R.G. Hart Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation J Am Coll Cardiol 20 1992 527 532
88. C. Rostagno, F. Bacci, M. Martelli, A. Naldoni, G. Bertini, G. Gensini Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode Am J Cardiol 76 1995 837 839
89. V. Snow, K.B. Weiss, M. LeFevre Management of newly detected atrial fibrillation a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians Ann Intern Med 139 2003 1009 1017
90. The AFFRIM Investigators Relationship between sinus rhythm, treatment, and survival in the atrial fibrillation follow up investigation of rhythm management (AFFRIM) study Circulation 109 2004 1509 1513
91. M.M. Gallagher, X.H. Guo, J.D. Poloniecki, Y. Guan Yap, D. Ward, A.J. Camm Initial energy sitting, outcome and efficiency in direct current cardioversion of atrial fibrillation J Am Coll Cardiol 38 2001 1498 1504
92. T. Lundstrom, L. Ryden Chronic atrial fibrillation long term results of direct current cardioversion Acta Med Scand 223 1988 53 59
93. B. Lown Electrical reversion of cardiac arrhythmias Br Heart J 29 1967 469 489
94. G.W. Dalzell, J. Anderson, A.A. Adgey Factors determining success and energy requirement for cardioversion of atrial fibrillation Q J Med 76 1990 903 913
95. H.C. Dittrich, J.S. Erikson, T. Schneideman, A.R. Blacky, T. Savides, P.H. Nicod Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation Am J Cardiol 63 1989 193 197
96. P. Kirchhof, L. Eckardt, P. Loh Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation Lancet 360 2002 1275 1279
97. B. Lown, R. Kleiger, G. Wolff The technique of cardioversion Am Heart J 67 1964 282 284
98. G.L. Botto, A. Politi, W. Bonini, T. Broffoni, R. Bonatti External cardioversion of atrial fibrillation role of paddle position on technique efficacy and energy requirements Heart 82 1999 726 730
99. R.J. Myerburg, A. Castellanos Electrode positioning for cardioversion of atrial fibrillation Lancet 360 2002 1263 1264
100. T.P. Mathew, A. Moore, M. McIntyre Randomized comparison of electrode positions for cardioversion of atrial fibrillation Heart 81 1999 576 579
101. R.E. Kerber, S.R. Jensen, J. Grayzel, J. Kennedy, R. Hoyt Elective cardioversion influence of paddle electrode location and size on success rates and energy requirements N Engl J Med 305 1981 658 662
102. P. Ricard, S. Levy, J. Trigano Prospective assessment of the minimum energy needed for external cardioversion of atrial fibrillation Am J Cardiol 79 1997 815 816
103. E.J. Rashba, R. Bouhouch, S. Koshy A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight Am J Cardiol 88 2001 1043 1045
104. J.A. Joglar, M.H. Hamdan, K. Ramaswamy Initial energy for elective external cardioversion of persistent atrial fibrillation Am J Cardiol 86 2000 348 350
105. R.L. Page, R.E. Kerber, J.K. Russell Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. The result of an international randomized, double-blind multicenter trial J Am Coll Cardiol 39 2002 1956 1963
106. S. Mittal, S. Ayati, K.M. Stein Transthoracic cardioversion of atrial fibrillation. Comparison of rectilinear versus damped sine wave monophasic shocks Circulation 101 2000 1282 1287
107. A. Capucci, G.O. Villani, D. Aschieri, A. Rosi, M.F. Piepoli Oral amiodarone increases the efficacy of direct current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation Eur Heart J 21 2000 66 73
108. H. Oral, J.J. Souza, G.F. Michaud Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment N Engl J Med 340 1999 1849 1854
109. A. De Simone, G. Stabile, D.F. Vitale Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion J Am Coll Cardiol 34 1999 810 814
110. A. De Simone, M. De Pasquale, C. De Matteris Verapamil, plus antiarrhythmic drugs reduce atrial fibrillation recurrences after electrical cardioversion (VEPARAF Study) Eur Heart J 24 2003 1425 1429
111. A.H. Madrid, M.G. Bueno, J.M. Rebollo Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study Circulation 106 2002 331 336
112. G. Boriani, I. Diemberger, M. Biffi, C. Martignani, A. Branzi Pharmacological cardioversion of atrial fibrillation current management and treatment options Drugs. 64 2004 2741 2762
113. C. Costeas, J. Kassotis, M. Blitzer, J.A. Reiffel Rhythm management in atrial fibrillation--with a primary emphasis on pharmacological therapy part 2 Pacing Clin Electrophysiol 21 1998 742 752
114. J. Azpitarte, M. Alvarez, O. Baun Value of single oral loading dose of propafenone in converting recent onset atrial fibrillation results of randomized double-blind, controlled study Eur Heart J 18 1997 1649 1654
115. A. Capucci, G.O. Villani, M.F. Piepoli, D. Aschieri The role of oral IC antiarrhythmic drugs in terminating atrial fibrillation Curr Opin Cardiol 14 1999 4 8
116. G. Boriani, M. Biffi, A. Capucci Conversion of recent onset atrial fibrillation to sinus rhythm. Effects of different drug protocols Pacing Clin Electrophysiol 21 1998 2470 2474
117. C.J. Bjerkelund, O.M. Oming The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation Am J Cardiol 23 1969 208 216
118. M. Berger, P. Schweitzer Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter a retrospective analysis Am J Cardiol 82 1998 1545 1547
119. G.W. Albers, J.E. Dalen, A. Laupacis, W.J. Manning, P. Petersen, D.E. Singer Antithrombotic therapy in atrial fibrillation Chest 119 2001 194S 206S
120. A.L. Klein, R.A. Grimm, I.W. Black Cardioversion guided by transesophageal echocardiography the ACUTE Pilot Study Ann Intern Med 126 1997 200 209
121. A.L. Klein, R.A. Grimm, R.D. Murray Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
122. E. Moreyra, R.S. Finkelhor, R.D. Cebul Limitation of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter an analysis of pooled trials Am Heart J 129 1995 71 75
123. I.W. Black, D. Fatkin, K.B. Sagar Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation a multicenter study Circulation 89 1994 2509 2513
124. C. Stellbrink, U. Nixdorff, T. Hofmann Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulation for prevention of thromboembolism complications in cardioversion of nonvalvular atrial fibrillation The anticoagulation in cardioversion using enoxaparin (ACE) trial Circulation 109 2004 997 1003
125. G. Nichol, F. McAlister, B. Pham Meta-analysis of randomized controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation Heart 87 2002 535 549
126. I.C. Van Gelder, H.J. Crijns, R.G. Tieleman Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation Arch Intern Med 165 1996 2585 2592
127. D. Roy, M. Talajic, P. Dorian Canadian Trial of Atrial Fibrillation Investigators Amiodarone to prevent recurrence of atrial fibrillation N Engl J Med 342 2000 913 920
128. G.E. Kochiadakis, N.E. Igoumenidis, M.E. Marketou Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation a comparative, placebo controlled study Heart 84 2000 251 257
129. S.C. Reimold, C.O. Cantillon, P.L. Friedman, E.M. Antman Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation Am J Cardiol 71 1993 558 563
130. R.G. Tieleman, A.T. Gosselink, H.J. Crijns Efficacy, safety, and determinants of cardioversion of atrial fibrillation and flutter with oral amiodarone Am J Cardiol 79 1997 53 57
131. K.K. Teo, S. Yusuf, C.D. Furberg Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled clinical trials JAMA 270 1993 1589-5
132. D.S. Echt, P.R. Liebson, L.B. Mitchell Mortality and morbidity in patients receiving ecainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
133. D.P. Zipes, J. Jalife Cardiac Electrophysiology from Cell to Bedside 4th ed. 2004 Saunders Philadelphia, PA
134. J.L. Cox, T.E. Canavan, R.B. Schuessler The surgical treatment of atrial fibrillation II Intraoperative electrophysiological mapping and description of the electrophysiological basis for atrial flutter and fibrillation J Thorac Cardiovasc Surg 101 1991 406 426
135. J.L. Cox The surgical treatment of atrial fibrillation IV. Surgical technique J Thorac Cardiovasc Surg 101 1991 584 592
136. J.L. Cox, J.P. Boineau, R.B. Schuessler Electrophysiological basis, surgical development, and clinical results of maze procedure for atrial flutter and atrial fibrillation Adv Card Surg 6 1995 1 67
137. J.L. Cox, J.P. Boineau, R.B. Schuessler Five years experience with the maze procedure for patients with atrial fibrillation Ann Thorac Surg 56 1993 814 823
138. K. Kosakai, S. Nakajima, Y. Kitoh Modified maze procedure for patients with atrial fibrillation undergoing simultaneous open heart surgery Circulation 92 1995 II359 II364
139. S. Lonnerholm, P. Blomstrom, L. Nilsson Effect of maze operation on health related quality of life in patients with atrial fibrillation Circulation 101 2000 2607 2611
140. H. Kottkamp, G. Hindricks, R. Autschbach Specific linear left atrial lesions in atrial fibrillation intraoperative radiofrequency ablation using minimally invasive surgical techniques J Am Coll Cardiol 40 2002 475 480
141. H.J. Crijns, I.C. Van Gelder, H.J. Van der Woude Efficacy of serial electrical therapy in patients with chronic atrial fibrillation after valve replacement and implication for surgery to cure atrial fibrillation Am J Cardiol 78 1996 1140 1144
142. H. Izumoto, K. Kawazoe, H. Kitahara, J. Kamata Operative results after the Cox/Maze procedure combined with a mitral valve operation Ann Thorac Surg 66 1998 800 804
143. K.B. Kim, K.R. Cho, D.W. Sohn, H. Ahn, J.R. Rho The Cox-Maze III procedure for atrial fibrillation associated with rheumatic mitral valve disease Ann Thorac Surg 68 1999 799 804
144. S. Yuda, G. Juncheng, T. Tabata, Z. Yanli, Y. Yuandi Long-term follow up of atrial contraction after the maze procedure in patients with mitral valve disease J Am Coll Cardiol 37 2001 1622 1627
145. T. Deneke, K. Khargi, P.H. Grewe Efficacy of an additional Maze procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized prospective trial Eur Heart J 23 2002 558 566
146. S. Yuda, S. Nakatani, F. Isobe, Y. Kosakai, K. Miyatake Comparative efficacy of the maze procedure for restoration of atrial contraction in patients with and without giant left atrium associated with mitral valve disease J Am Coll Cardiol 31 1998 1097 1102
147. T. Nitta, Y. Ishii, H. Ogasawara Initial experience with the radial incision approach for atrial fibrillation Ann Thorac Surg 68 1999 805 810
148. M. Haissaguerre, P. Jais, D.C. Shah Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
149. S.A. Chen, M.H. Hsieh, C.T. Tai Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. Electrophysiologic characteristics, pharmacologic responses, and effects of radiofrequency ablation Circulation 100 1999 1879 1886
150. D.C. Shah, M. Haissaguerre, P. Jais Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients strategy for presentations ranging from sustained atrial fibrillation to no arrhythmias Pacing Clin Electrophysiol 24 2001 1541 1558
151. M. Haissaguerre, P. Jais, D.C. Shah Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci Circulation 101 2000 1409 1417
152. T. Dill, T. Neumann, O. Ekinci Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging Circulation 107 2003 845 850
153. A. Natale, E. Pisano, J. Shewchik First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation Circulation 102 2000 1879 1882
154. H. Oral, B.P. Knight, H. Tada Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation Circulation 105 2002 1077 1081
155. C. Pappone, S. Rosanio, G. Oreto Circumferential radiofrequency ablation of pulmonary vein ostia a new anatomic approach for curing atrial fibrillation Circulation 102 2000 2619 2628
156. P. Schauerte, B.J. Scherlag, J. Pitha Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation Circulation 102 2000 2774 2780
157. H.R. Andersen, J.C. Nielsen, P.E. Thomsen Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome Lancet 350 1997 1210 1216
158. A.C. Skanes, A.D. Krahn, R. Yee CTOP Investigators Progression to chronic atrial fibrillation after pacing the Canadian Trial of Physiologic Pacing J Am Coll Cardiol 38 2001 167 172
159. G.A. Lamas, K.L. Lee, M.O. Sweeney Ventricular pacing or dual-chamber pacing for sinus-node dysfunction N Engl J Med 346 2002 1854 1862
160. S.J. Connolly, C.R. Kerr, M. Gent Effect of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes Canadian Trial of Physiologic Pacing Investigator N Engl J Med 342 2000 1385 1391
161. P.B. Sparks, H.G. Mond, J.K. Vohra Electrical remodeling of the atria following loss of atrioventricular synchrony. A long-term study in humans Circulation 100 1999 1894 1900
162. T. Sato, D.P. Zipes Unequal atria stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation J Cardiovasc Electrophysiol 7 1996 833 842
163. A. Prakash, P. Delfaut, R.B. Krol, S. Saksena Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation Am J Cardiol 82 1998 1197 1204
164. P. Delfaut Long-term outcome of patients with drug refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention J Am Coll Cardiol 32 1998 1900 1908
165. T. Levy, S. Walker, S. Rex, J. Rochelle, V. Paul No incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation Heart 85 2001 48 52
166. C.P. Lau, H.F. Tse, C.M. Yu Dual-site atrial pacing for atrial fibrillation in patients without bradycardia Am J Cardiol 88 2001 371 375
167. J.F. Leclercq, A. De Sisti, P. Fiorello, F. Halimi, S. Manot, P. Attuel Is dual site better than single site atrial pacing in the prevention of atrial fibrillation? Pacing Clin Electrophysiol 23 2000 2101 2107
168. S. Saksena, A. Prakash, M. Hill Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing J Am Coll Cardiol 28 1996 687 694
169. C.W. Israel, T. Lawo, B. Lemke, G. Gronefeld, S.H. Hohnloser Atrial pacing in the prevention of paroxysmal atrial fibrillation first results of a new combined algorithm Pacing Clin Electrophysiol 23 2000 1888 1890
170. R.C. Funck, R. Adamec, L. Lurje Atrial overdrive pacing is beneficial in patients with atrial arrhythmia first results of the PROVE Study Pacing Clin Electrophysiol 23 2000 1891 1893
171. J.M. Rawles What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J 63 1990 157 161
172. A. Roth, E. Harrison, G. Mitani, J. Cohen, S.H. Rahimtoola, U. Elkayam Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation Circulation 73 1986 316 324
173. E.G. Daoud, R. Weiss, M. Bahu Effect of an irregular ventricular rhythm on cardiac output Am J Cardiol 78 1996 1433 1436
174. R.H. Falk, J.I. Leavitt Digoxin for atrial fibrillation a drug whose time is gone? Ann Intern Med 114 1991 573 575
175. B.H. Sarter, F.E. Marchlinski Redefining the role of digoxin in the treatment of atrial fibrillation Am J Cardiol 69 1992 71G 78G
176. B. Olshansky, L.E. Rosenfeld, A.L. Warner The atrial fibrillation follow-up investigation of rhythm management (AFFRIM) study approaches to control rate in atrial fibrillation J Am Coll Cardiol 43 2004 1201 1208
177. K.K. Koh, J.H. Song, K.S. Kwon Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation randomized crossover study Int J Cardiol 52 1995 167 174
178. R. DiBianco, J. Morganroth, J.A. Freitag Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin Am Heart J 108 1984 1121 1127
179. R. Farshi, D. Kistner, J.S. Sama, J.A. Longmate, B.N. Singh Ventricular rate control in atrial fibrillation during daily activity and programmed exercise a crossover open-label study of five drug regimens J Am Coll Cardiol 33 1999 304 310
180. D.M. Salerno, V.C. Dias, R.E. Kleiger Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter Am J Cardiol 63 1989 1046 1051
181. K.A. Ellenbogen, V.C. Dias, F.P. Cardello Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter Am J Cardiol 75 1995 45 49
182. R. Weerasooriya, M. Davis, A. Powell The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT) J Am Coll Cardiol 41 2003 1697 1702
183. R.P. Fleck, P.S. Chen, K. Boyce, R. Ross, H.C. Dittrich, C.K. Feld Radiofrequency modification of atrioventricular conduction by selective ablation of the low posterior septal right atrium in a patient with atrial fibrillation and a rapid ventricular response Pacing Clin Electrophysiol 16 1993 377 381
184. B.D. Williamson, K.C. Man, E. Daoud, M. Niebauer, S.A. Strickberger, F. Morady MCDE. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation N Engl J Med 331 1994 910 917
185. M.M. Scheinman, S. Huang The 1998 NASPE prospective catheter ablation registry Pacing Clin Electrophysiol 23 2000 1020 1028
186. S. Lee, S.A. Chen, C.T. Tai Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation J Am Coll Cardiol 31 1998 637 644
187. M. Brignole, L. Gianfranchi, C. Menozzi Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation a randomized controlled study Circulation 96 1997 2617 2624
188. M. Brignole, C. Menozzi, G. Gaggioli Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation Circulation 98 1998 953 960
189. R. Willems, D.G. Wyse, A.M. Gillis Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy J Cardiovasc Electrophysiol 14 2003 1296 1301
190. C. Ozcan, A. Jahangir, P.A. Friedman Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation N Engl J Med 344 2001 1043 1051
191. C. Ozcan, A. Jahangir, P.A. Friedman Sudden death after radiofrequency ablation of the atrioventricular junction ablation in patients with chronic atrial fibrillation J Am Coll Cardiol 40 2002 105 110
192. F.H. Wittkampf, M.J. de Jongste, H.I. Li, F.L. Meijler Effect of right ventricular pacing on ventricular rhythm during atrial fibrillation J Am Coll Cardiol 11 1988 539 545
193. M.A. Wood Trials of pacing to control ventricular rate during atrial fibrillation J Inter Card Electrophysiol 10S 2004 63 70
194. C. Simpson, R. Yee, J.K. Lee Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation Am Heart J 142 2001 294 300
195. I.A. Olivotto, F. Cecchi, S.A. Casey, A. Dolars, J.H. Traverse, B.J. Maron Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524
196. P. Mahoney, S. Kimmel, D. DeNofrio, P. Wahl, E. Loh Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure Am J Cardiol 83 1999 1544 1547
197. J.A. Joglar, A.P. Acusta, N.H. Shusterman Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction Retrospective analysis of the US carvedilol heart failure trials program Am Heart J 142 2001 498 501
198. D. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, L.W. Stevenson Atrial fibrillation in association with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction a retrospective analysis of the SOLVED trial J Am Coll Cardiol 32 1998 695 703
199. W.G. Stevenson, L.W. Stevenson, H.R. Middlekauff Improving survival for patients with atrial fibrillation and advanced heart failure J Am Coll Cardiol 28 1996 1458 1463
200. P.E. Carson, G.R. Johnson, W.B. Dunkman, R.D. Fletcher, L. Farrell, J.N. Cohen The influence of atrial fibrillation on prognosis in mild-moderate heart failure V-HeFT studies Circulation 87 1993 VI102 VI110
201. The AF-CHF Investigators Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure the atrial fibrillation and heart failure (AF-CHF) trial Am Heart J 144 2002 597 607